Compare Relay Therapeutics Inc. Common Stock (RLAY) vs SPDR Kensho Final Frontiers ETF (ROKT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Relay Therapeutics Inc. Common Stock vs SPDR Kensho Final Frontiers ETF — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B), while SPDR Kensho Final Frontiers ETF trades at $102.84 (market cap $176.19M). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 22.4× SPDR Kensho Final Frontiers ETF's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, SPDR Kensho Final Frontiers ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and SPDR Kensho Final Frontiers ETF for 8 Days on average.
| RLAY | ROKT | |
|---|---|---|
Market Cap | $3.94B | $176.19M |
Volume | 3,432,928 | 34,479 |
Sector | Health | Sector/Thematic |
52-Week High | $20.75 | $136.68 |
52-Week Low | $6.03 | $72.93 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $3.06B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →About SPDR Kensho Final Frontiers ETF
SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →
